Tert-butyl (2R,3R)-3-hydroxy-2-methylpyrrolidine-1-carboxylate, 98%, 5g

4-(Dodecyloxy)benzoic acid, 95.0%, 10g

4-Chloro-2-fluorophenyl cyclopropyl ketone, 97.0%, 1g

4-Bromo-3,5-dimethyl-benzonitrile, 99.00%, 100g

6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide, 99+%, 100mg

Matrine, 95.0%, 1g

3-((tert-Butoxycarbonyl)amino)-3-(o-tolyl)propanoic acid, 98%, 5g

3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate>97.0%(N)1g

3-Cyano-1H-pyrrole-2-carboxylic acid, 95%, 250mg

Méthanol D3, 99,5 at%D, 5 ml, emballage en verre

3-chloro-1,2,4-thiadiazol-5-amine, 98%, 1g

4-Bromo-2-cyclobutylpyridine, 95.0%, 250mg

4'-(2,4-Difluorophenoxy)acetophenone, 95.0%, 25g